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RESUMO: “Efeito relaxante do extrato aquoso das folhas de Erythrina vellutina em ducto 
deferente de rato”. O objetivo deste trabalho foi avaliar o efeito do extrato aquoso das folhas 
de Erythrina vellutina (AE) sobre ducto deferente de rato. Nesta preparação, o AE inibiu as 
contrações induzidas por estímulo elétrico de campo de maneira dependente da concentração. 
Esta inibição não foi afetada após atropina (10-5M), propanolol (10-5M), prazosin (10-5M) ou 
yohimbina (10-5M), sugerindo uma ação indireta do AE sobre receptores colinérgicos ou 
adrenérgicos. A incubação da preparação com os antagonistas de canais de K+, tetraetilâmonio 
(10-6M) ou 4-aminopiridina (10-6M) não alterou o efeito inibitório induzido pelo AE. Entretanto, a 
glibenclamida (10-6M) atenuou signifi cantemente este efeito, sugerindo um possível envolvimento 
de canais de K+ dependentes de ATP. Além disso, o AE (0.15 mg/mL) não alterou as contrações 
induzidas por noradrenalina (10-5M), ATP (10-4M) ou KCl (80 mM), descartando uma interação 
do AE com um sítio pós-sináptico. Em conclusão, estes resultados demonstram que o efeito 
inibitório do AE pode ser devido a uma interação pré-sináptica com canais de K+ dependentes de 
ATP em neurônios simpáticos de ducto deferente de rato.
Unitermos: Erythrina vellutina, ducto deferente de rato, canal de K+ dependente de ATP.
ABSTRACT: The effect of the Aqueous Extract from the leaves of Erythrina vellutina (AE) on 
rat vas deferens preparation was evaluated in this work. The AE inhibited the muscle contractions 
induced by electrical fi eld stimulation (EFS) in a concentration-dependent manner. This inhibition 
was not affected by atropine (10-5M), propanolol (10-5M), prazosin (10-5M) or yohimbine (10-
5M), suggesting that there is no direct interaction of the AE with cholinergic nor adrenergic 
receptors. Incubation of vas deferens with the K+ channel antagonists, tetraethylamonium (10-
6M) or 4-aminopyridine (10-6M) had also no effect on the AE-induced inhibition. On the other 
hand, glibenclamide (10-6) signifi cantly attenuated the effect of the AE, suggesting a possible 
involvement of ATP-dependent K+ channels. The AE (0.15 mg/mL) did not alter the contractions 
induced by noradrenaline (10-5M), ATP (10-4M) nor KCl (80 mM), against an interaction of the 
extract with post-synaptic sites. The data presented suggests that the inhibition of the electrically 
driven muscle twitches by the AE could be due to a pre-synaptic interaction of the extract with 
ATP-dependent K+ channels from vas deferens sympathetic neurons.
Keywords: Erythrina vellutina, rat vas deferens, ATP-dependent K+ channel.
INTRODUCTION
The  genus  Erythrina  (Leguminosae)  Milld, with 
at least 110 species identifi ed (Vasconcelos et al., 2003), 
has attracted the attention of many scientists, probably 
because some of the Erythrina species have been used 
in folk medicine from South and North America (Garín-
Aguilar et al., 2000) to Africa (El-Olemy et al., 1983) 
and Asia (Telikepalli et al., 1990; Kòbaiashi et al., 1997; 
Hegde et al., 1997). In Brazilian folk medicine, different 
species of Erythrina are used for the treatment of central 
nervous system (CNS) diseases such as nervous system 
excitation, insomnia, convulsions and nervous coughs 
(Teske; Trentini, 1995; Matos, 1997; Agra et al., 2007). 
Despite previous studies have demonstrated that extracts 
of E. velutina possesse effects on the CNS (Dantas et al., 
2004, Vasconcelos et al., 2004, Ribeiro et al., 2006) and 
antibacterial (Virtuoso et al., 2005), its mechanism of 
action still remain unclear.
The rat vas deferens preparation is a classical 
model for the study of substances that interfere with 
the mechanisms of cholinergic, noradrenergic and 
purinergic neurotransmission. Knoll et al. (1972) 
showed that acetylcholine is released in a frequency-
dependent manner and that it interacts with muscarinic 
receptors to promote muscle contraction. It also binds 
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to nicotinic receptors from adrenergic varicosities 
resulting in noradrenaline release (Carneiro; Markus, 
1990). Noradrenaline appears to be the main transmitter 
in rat vas deferens and its effects are abolished by α-
adrenergic but not by β-adrenergic antagonists (Brown 
et al., 1983). There are also strong evidences for the 
participation of a non-cholinergic and non-adrenergic 
neurotransmitter in rat vas deferens (Sneddon et al., 
1982; Sneddon; Burnstock, 1984). ATP appears to be 
one of the transmitters since it was demonstrated in this 
preparation a P2 receptor-dependent effect (Sneddon et 
al., 1982).
In this work we used the rat vas deferens 
preparation to evaluate the effects of the aqueous extract 
from the leaves of Erythrina vellutina on the peripheral 
nervous system.
MATERIAL AND METHODS
Animals
 Male Wistar rats (200-300 g) were used in all 
experiments. Animals were housed in temperature of 25 
± 1 ºC, clear/dark cycle of 12/12 hours, feeding with 
PURINE and water ad libtum. All procedures described 
in the present work are in agreement with the rules of 
the Animal Research Ethics Committee of Universidade 
Federal de Sergipe (UFS).
Plant material
 Erythrina vellutina leaves were collected on the 
campus of the UFS, at Aracaju-SE, Brazil, and a voucher 
specimen was deposited at the University herbarium 
under the number ASE 4126. The leaves were dried at 
40 oC until complete dehydration, and then triturated in 
a blender until a fi nely granulated powder was obtained. 
The aqueous extract was obtained from this powder by 
adding distilled water (1:10, w/v) for 30 min at 100 oC. 
After fi ltration, the extract was lyophilized and stored at 
5 oC for later use. For the pharmacological experiments, 
the lyophilised extract was diluted at a concentration of 
50 mg/mL.
Tissue preparation
The animals were sacrifi ced by cervical 
dislocation and the vas deferentia were removed by a 
medial incision in the abdominal cavity. After being 
removed they were dissected further to remove the 
excess of adipose tissue. 10 to 12 mm segments were 
suspended by a platinum electrode on a heated (37 oC) 
10 mL organ bath, in a Krebs solution (containing in 
mM: NaCl, 118; KCl, 4.6; CaCl22H2O, 2.9; KH2PO4, 
1.17; MgCl26H2O, 1.31; NaHCO3, 25, Glucose, 11.1), 
bubbled with an mixture of 95% O2 and 5% CO2. The 
isometric contractions were recorded with a Gould 
force transducer under a resting tension of 1g. Tissues 
were equilibrated for at least 60 min with bath solution 
changes every 15 min. 
Experiments involving electrical fi eld stimulation
 After equilibrium was achieved, vas deferens 
segments were submitted to a continuous electrical 
fi eld stimulation (EFS) (0.15 Hz, 1 ms, supramaximum 
voltage). Cumulative concentration-response curves  were 
obtained  with  the  addition of different concentrations 
of the AE (0.05, 0.15, 0.5 and 1.5 mg/mL) and pinacidil 
(PIN) (10-8 to 3.10-6M), during the electrical stimulation, 
in the absence and presence of glibenclamide (GLIB) 
(10-6M). In other set of experiments, AE was added to 
bath in a single dose (0.15 mg/mL) and its relaxant 
effect was compared before and after incubation for 20 
min with atropine (ATR) (10-5M), propranolol (PRP) 
(10-5M), prazosin (PZS) (10-5M), yohimbine (YHB) (10-
5M), glibenclamide (GLIB) (10-6M), 4-aminopyridine 
(4-AP) (10-6M), tetraethylamonium (TEA) (10-6M) or 
dimetilsulfoxide (DMSO), separately. The dose of 0.15 
mg/mL of the AE was chosen for these experimental 
protocols because it was the dose able in induced 50 % 
of inhibitory effect.
Experiments involving exogenous applied drugs
 The responses of the vas deferens were 
evaluated for noradrenaline (NA) (10-5M), ATP (10-4M) 
and KCl (80 mM) in the absence and presence of the 
AE. After two similar and consecutive responses were 
obtained, the preparation was incubated with 0.15 mg/
mL of the AE 20 min before recording a new response.
Drugs
 Pinacidil, prazosin, propanolol, yohimbine, 
tetarethylamonium and glibenclamide were purchased 
from RBI. Noradrenaline and 4-aminopyridine were 
from SIGMA and atropine was purchased from MERK. 
Pinacidil and glibenclamide were diluted in DMSO 
(fi nal concentration in organ bath: 0.1%), while other 
drugs were diluted in distilled water.
Statistical analysis
 The results are presented as mean ± s. e. mean 
and were analysed by the Graph Pad Prism program 
3.02. The differences were estimated by the Student’s 
t test for comparison of two means, with the level of 
signifi cance set at p < 0.05.
RESULTS AND DISCUSSION
As showed in Figure 1, addition of the AE 
to the preparation reduced the contractions induced 
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Figure 1. Original traces of: A - Concentration-response curve showing the effect of the 
aqueous extract of E. vellutina (AE) (0.05, 0.15, 0.5 and 1.5 mg/mL) on the electrical fi eld 
stimulation induced contractions of the rat vas deferens and B - the full recovery to the basal 
contractions after washing.
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Figure 2. Effects of: (A) - atropine (ATR) (10-5M), propanolol (PRP) (10-5M), prazosin (PZS) (10-5M) and yohimbine (YHB) (10-
5M) and (B) - glibenclamide (GLIB) (10-6M), 4-aminopyridine (4-AP) (10-6M), tetraethylamonium (TEA) (10-6M) and DMSO on 
the relaxation induced by the aqueous extract of E. vellutina (AE) (0.15 mg/mL) on the rat vas deferens. The values are expressed 
as mean ± s.e.mean of six experiments. ** p < 0.01 vs AE.
by EFS in a concentration-dependent manner. At 
increasing concentrations (0.05-1.5 mg/mL) the AE 
practically abolished the contractions induced by the 
electrical stimulation. This effect was reversed, after 
5 min of washing, demonstrated a possible absence of 
desensitisation (Figure 1).
One hypothesis to explain the inhibitory effects 
of the AE would be an interaction with cholinergic or 
noradrenergic receptors from vas deferens sympathetic 
neurons. The preparation was then incubated with AE 
(0.15 mg/mL), in the presence of atropine (10-5M), a 
cholinergic muscarinic antagonist, propanolol (10-5M), 
a non-selective β-adrenergic antagonist, prazosin (10-
5M), a α1-adrenergic antagonist or yohimbine (10-5M), 
a α2-adrenergic antagonist, separately. As illustrated in 
Figure 2A none of the antagonists tested interfered with 
the AE inhibition of vas deferens contraction (p < 0.05, 
n = 6), suggesting that there is no direct interaction of 
the extract with cholinergic or adrenergic receptors.
 In the next step to evaluate a possible 
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Figure 3. Effect of glibenclamide (GLIB) (10-6M) on: (A) - the relaxation induced by aqueous extract of E. vellutina (AE) (0.05, 
0.15, 0.5 and 1.5 mg/mL) and (B) - by pinacidil (PIN) (10-8 - 10-5 M) during the electrical fi eld stimulation of the rat vas deferens. 
The values are expressed as mean ± s.e.mean of six experiments. ** p < 0.01 vs AE or PIN.
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Figure 4. Effect of the aqueous extract of E. vellutina (AE) (0.15 mg/mL) on the noradrenaline 
(NA) (10-5M) and ATP (10-4M) induced contractions of the rat vas deferens. The values are 
expressed as mean ± s.e.mean of six experiments. 
involvement of K+ channels in the inhibitory effect of 
the AE. The vas deferens was incubated, in the presence 
of 1.5 mg/mL of the AE, with antagonists for some 
known subtypes of K+ channels: tetraethylamonium 
(10-6M), for Ca2+-dependent K+ channels (Latorre et 
al., 1989), 4-aminopyridine (10-6M) for the delayed 
rectifi er and A type K+ channels (Thompson, 1977), 
and glibenclamide (10-6M) for the ATP-dependent K+ 
channels (Kalei et al., 1985). As showed in Figure 2B, 
only glibenclamide interfered with the effect of the EA 
(p<0.01, n = 6), suggesting a possible involvement of 
ATP-dependent K+ channels in the relaxant effects of the 
AE. In order to confi rm this hypothesis, we performed 
a concentration-response curve to AE (0.05, 0.15, 0.5 
and 1.5 mg/mL) during the electrical fi eld stimulation 
of the rat vas deferens in the absence and presence of 
glibenclamide (10-6M). In this condition, AE induced 
relaxation which was attenuated by glibenclamide in all 
concentrations (Figure 3A). Similarly, pinacidil (10-8-
3.10-6 M), a specifi c agonist for the ATP-dependent K+ 
channels (Grana et al., 1997), also induced relaxation 
which was also inhibited by glibenclamide (10-6M) (p 
< 0.01; n = 6) (Figure 3B). These results demonstrated 
that, at least in part, ATP-dependent K+ channels play 
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Figure 5. Effect of the aqueous extract of E. vellutina (AE) (0.15 mg/mL) on the KCl (80 mM) 
induced contractions of the rat vas deferens. The values are expressed as mean ± s.e.mean of six 
experiments.
important role in the AE-induced relaxant effect. (Figure 
2A and B)
The specifi c interaction of the AE with 
ATP-dependent K+ channels suggests a possible pre-
synaptic modulation of the extract, since it was recently 
demonstrated that this subtype of K+ channel causes 
vas deferens relaxation by inhibiting ATP release from 
the nerve endings of adrenergic terminals (Grana et al., 
1997). (Figure 3A and B)
The co-transmission of noradrenaline and ATP 
is well established for the rat vas deferens (French; 
Scott, 1983; Sneddon; Burnstock, 1984). Thus, in 
order to check a possible post-synaptic action of the 
AE, the vas deferens were contracted by application 
of noradrenaline (NA) (10-5M) or ATP (10-4M) without 
electrical stimulation and in the absence and presence 
of AE (0.15 mg/mL). As showed in Figure 4 the AE 
did not alter the NA and ATP induced contractions (n 
= 6). Finally, we tested the effects of the AE on the 
contraction induced by KCl (80 mM). As is clear from 
Figure 5, the AE did not interfere with the contraction 
induced by KCl depolarisation (p > 0.05; n = 6). (Figure 
4 and Figure 5).
Taken together, the data described above 
suggests that the inhibition of the electrically driven 
muscle twitches by the AE is probably due to a pre-
synaptic interaction of the extract with ATP-dependent 
K+ channel from vas deferens sympathetic neurons.
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